XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
XORTX Therapeutics Inc., a company specializing in kidney disease treatments, has successfully conducted its annual and special shareholder meeting with key approvals and board elections. The meeting led to the reelection of seven board members and advanced the company’s intellectual property and research in treating polycystic kidney disease. The company’s focus on innovative therapies continues to show promise in improving patient health and quality of life.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
